Yuanfei Shi Selected Research

Yuanfei Shi Research Topics

8	Neoplasms (Cancer) 01/2024 - 10/2019
6	Leukemia 04/2022 - 01/2018
5	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 04/2022 - 06/2019
3	Carcinogenesis 10/2020 - 10/2019
2	Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse) 07/2023 - 10/2022
2	Lymphoma (Lymphomas) 01/2021 - 01/2018
1	Hypoxia (Hypoxemia) 01/2024
1	B-Cell Lymphoma (Lymphoma, B Cell) 01/2021
1	Hematologic Neoplasms (Hematological Malignancy) 01/2021
1	Peripheral T-Cell Lymphoma (Lymphoma, T Cell, Peripheral) 01/2020
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2018

4	venetoclaxIBA 07/2023 - 01/2021
4	apatinibIBA 10/2022 - 01/2018
3	chiauranibIBA 01/2021 - 01/2018
2	triptolideIBA 04/2022 - 01/2020
2	HomoharringtonineIBA 01/2022 - 01/2021
2	Proteins (Proteins, Gene)FDA Link 01/2021 - 10/2020
1	CatalaseIBA 01/2024
1	Radioisotopes (Radionuclides)IBA 01/2024
1	nutlin 3IBA 04/2022
1	Vascular Endothelial Growth Factor Receptors (VEGF Receptors)IBA 01/2022
1	RNA Polymerase II (RNA Polymerase B)IBA 01/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	6-methyladenineIBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	N- (2- amino- 5- fluorobenzyl)- 4- (N- (pyridine- 3- acrylyl)aminomethyl)benzamideIBA 10/2019
1	Histone Deacetylases (Histone Deacetylase)IBA 10/2019
1	Histone Deacetylase InhibitorsIBA 10/2019